the patients who perform vitreous surgery
Conditions
Interventions
Triamcinolone acetonide
Sponsors
Department of Ophthalmology, Yamaguchi University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: the patient who will perform vitreous surgery
Exclusion criteria
Exclusion criteria: 1)The contraindications item in a triamcinolone acetonide package leaflet (1)This agent ingredient hypersensitivity 2)The contraindications item at the time of whole body medication of a steroid hormone agent (1)The patient of the infection in which effective antibacterial medicine does not exist, and the mycosis of the whole body, (2) The patient of digestive ulcer, (3) The patient of a mental disease, (4) The patient of a tubercular disease, (5) The patient of simple herpetic keratitis, (6)The patient of after cataract, (7)The patient of glaucoma, (8)The patient of hypertension, (9)The patient with electrolyte abnormalities, (10)The patient of thromboses, (11)The patient with the operative wound of the recent internal organs, and (12) acute myocardial infarction, (13)The patient judged that medication of a steroid hormone agent is not desirable for the caused eye disease of a patient and others, or systemic illness 3)The patient who this research responsibility (assignment) doctor accepted was unsuitable as a subject 4)The participation in other clinical study is unquestioned.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| complications in vitreous surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| visual acuity, ocular pressure, fundus examination, postoerative complications | — |
Countries
Japan
Contacts
Public ContactKazuhiro Kimura
Yamaguchi University Graduate School of Medicine Ophthalmology
Outcome results
None listed